|
|
|
||
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange
on which registered
|
||
|
|
|
Item 3.01 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
|
CHEMBIO DIAGNOSTICS, INC.
|
||
Date: April 6, 2023
|
By:
|
/s/ Lawrence J. Steenvoorden
|
Name:
|
Lawrence J. Steenvoorden
|
|
Title:
|
Executive Vice President and Chief Financial Officer
|
Document and Entity Information |
Apr. 06, 2023 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Apr. 06, 2023 |
Entity File Number | 001-35569 |
Entity Registrant Name | CHEMBIO DIAGNOSTICS, INC. |
Entity Central Index Key | 0001092662 |
Entity Incorporation, State or Country Code | NV |
Entity Tax Identification Number | 88-0425691 |
Entity Address, Address Line One | 3661 Horseblock Road |
Entity Address, City or Town | Medford |
Entity Address, State or Province | NY |
Entity Address, Postal Zip Code | 11763 |
City Area Code | 631 |
Local Phone Number | 924-1135 |
Title of 12(b) Security | Common Stock, par value $0.01 per share |
Trading Symbol | CEMI |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
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end
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end